How CUE-221’s Phase 2 Results In CSU Could Translate To Food Allergy
The “dual-mechanism” anti-IgE antibody CUE-221 has delivered encouraging phase 2 results in chronic spontaneous urticaria. Could it separate from omalizumab and ozureprubart in food allergy?